NQD-19077-09959
2 vaccinations
6 coded responses
23 check-ins
6 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 493 / MI
- Registered
- 2021-06-22
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-06-22
Registered in v-safe
-
2021-06-22
Dose 1 — Pfizer-BioNTech
- 2021-06-22
- 2021-06-23
-
2021-06-24
Survey response — days 1–6 daily, dose 1MedDRA: Chest discomfort — Feeling: GoodFree text: Chest heavinessMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-06-25
- 2021-06-26
- 2021-06-27
-
2021-06-28
Survey response — days 1–6 daily, dose 1MedDRA: Chest pain — Feeling: Fair · Headache, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesFree text: Mild chest pain, on my periodMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-06-29
Survey response — day 7, dose 1MedDRA: Unevaluable event — Feeling: Fair · Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesFree text: On my periodMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-07-06
Survey response — day 14, dose 1MedDRA: Dyspepsia, Nausea — Feeling: GoodFree text: Nausea and indigestion.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-07-13
Dose 2 — Pfizer-BioNTech
-
2021-07-15
Survey response — days 1–6 daily, dose 2MedDRA: Dyspepsia — Feeling: Good · Headache, Fatigue or tiredness, NauseaFree text: Heart burnMedDRA releases: 2021-09,2024-11 · check-in free text available
- 2021-07-16
- 2021-07-17
- 2021-07-18
- 2021-07-19
- 2021-07-20
- 2021-07-29
- 2021-08-03
- 2021-08-10
- 2021-08-17
- 2021-08-24
- 2021-10-12
- 2022-01-11
-
2022-07-13
Survey response — 12 months, dose 2MedDRA: Pregnancy — Feeling: Good · Be unable to work or attend schoolFree text: Pregnancy - weight lifting restrictions prevent me from working.MedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-06-22 | Pfizer-BioNTech | No |
| 2 | 2021-07-13 | Pfizer-BioNTech | No |
Free text
Release 9 — days 1–6 daily, dose 1
Systemic reaction (other): Chest heaviness
Systemic reaction (other): Mild chest pain, on my period
Release 9 — day 7, dose 1
Systemic reaction (other): On my period
Release 9 — day 14, dose 1
Symptoms: Nausea and indigestion.
Release 9 — days 1–6 daily, dose 2
Systemic reaction (other): Heart burn
Release 12 — 12 months, dose 2
Symptoms: Pregnancy - weight lifting restrictions prevent me from working.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Dyspepsia | ✓ | ✓ | ✓ |
| SD | Nausea | ✓ | ✓ | ✓ |
| SD | Pregnancy | · | · | ✓ |
| SRO | Chest discomfort | ✓ | ✓ | ✓ |
| SRO | Chest pain | ✓ | ✓ | ✓ |
| SRO | Dyspepsia | ✓ | · | ✓ |
| SRO | Unevaluable event | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release